Safety and clinical performance of a drug eluting absorbable metal scaffold in the treatment of subjects with de novo lesions in native coronary arteries: Pooled 12 ‐month outcomes of BIOSOLVE‐II and BIOSOLVE‐III

Catheterization and Cardiovascular Interventions, EarlyView.

Source: Catheterization and Cardiovascular Interventions - August 6, 2018 Category: Cardiovascular & Thoracic Surgery Authors: MichaelHaude , H üseyinInce , StephanKische , AlexandreAbizaid , RalphTölg , PedroAlves Lemos , Nicolas M.Van Mieghem , StefanVerheye , Clemensvon Birgelen , Evald HøjChristiansen , EmanueleBarbato , Hector M.Garcia� Source Type: research